Paraplatin and Atelectasis - a phase IV clinical study of FDA data
Summary:
Atelectasis is reported as a side effect among people who take Paraplatin (carboplatin), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Taxol, and have Lung cancer - non-small cell.
The phase IV clinical study analyzes which people have Atelectasis when taking Paraplatin. It is created by eHealthMe based on reports of 12,385 people who have side effects when taking Paraplatin from the FDA, and is updated regularly.
What is Paraplatin?
Paraplatin has active ingredients of carboplatin. eHealthMe is studying from 12,392 Paraplatin users. Check the latest studies of Paraplatin.
What is Atelectasis?
Atelectasis (partial or complete collapse of the lung) is found to be associated with 1,434 drugs and 1,638 conditions by eHealthMe. Check the latest studies of Atelectasis.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
12,385 people reported to have side effects when taking Paraplatin.
Among them, 17 people (0.14%) have Atelectasis.

Among these 17 people:
How long have people been on Paraplatin when they have Atelectasis? *
- < 1 month: 0.0 %
- 1 - 6 months: 100 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Atelectasis when taking Paraplatin? *
- female: 52.94 %
- male: 47.06 %
What is the age of people who have Atelectasis when taking Paraplatin? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 11.11 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 22.22 %
- 60+: 66.67 %
What are other drugs people take besides Paraplatin? *
- Taxol: 12 people, 70.59%
- Gemzar: 4 people, 23.53%
- Zofran: 3 people, 17.65%
- Tylenol: 2 people, 11.76%
- Famotidine: 2 people, 11.76%
- Avastin: 2 people, 11.76%
- Ativan: 2 people, 11.76%
- Decadron: 2 people, 11.76%
- Dexamethasone Sodium Phosphate: 2 people, 11.76%
- Benadryl: 2 people, 11.76%
What are other side effects people have besides Atelectasis? *
- Nausea (feeling of having an urge to vomit): 4 people, 23.53%
- Back Pain: 4 people, 23.53%
- Pleural Effusion (water on the lungs): 4 people, 23.53%
- Pneumonia: 4 people, 23.53%
- Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 4 people, 23.53%
- Joint Pain: 4 people, 23.53%
- Lung Disorder (lung disease): 3 people, 17.65%
- Bone Pain: 3 people, 17.65%
- Death: 3 people, 17.65%
- Nausea And Vomiting: 3 people, 17.65%
What are the existing conditions these people have? *
- Lung Cancer - Non-Small Cell (lung cancer): 2 people, 11.76%
- Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 1 person, 5.88%
- Osteoporosis (bones weak and more likely to break): 1 person, 5.88%
- Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 1 person, 5.88%
- Metastases To Bone (cancer spreads to bone): 1 person, 5.88%
- Malignant Lymphoid Neoplasm (malignant growth or tumour caused by abnormal and uncontrolled cell division in lymph node): 1 person, 5.88%
- Lung Neoplasm Malignant (cancer tumour of lung): 1 person, 5.88%
- Lung Cancer - Small Cell (lung cancer): 1 person, 5.88%
- Lung Adenocarcinoma Stage Iv (the cancer has spread to other organs of the body, such as the other lung, brain, or liver): 1 person, 5.88%
- Breast Cancer Metastatic: 1 person, 5.88%
* Approximation only. Some reports may have incomplete information.
Do you take Paraplatin and have Atelectasis?
- Check whether Atelectasis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Paraplatin:
- Paraplatin (12,392 reports)
Atelectasis treatments and more:
- Atelectasis (17,087 reports)
How severe was Atelectasis and when was it recovered:
Expand to all the drugs that have ingredients of carboplatin:
- Atelectasis and drugs with ingredients of carboplatin (477 reports)
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Paraplatin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Atelectasis:
- Atelectasis (1,434 drugs)
Browse all the conditions that are associated with Atelectasis:
- Atelectasis (1,638 conditions)
Related publications that referenced our studies
- Zakaria S, Lu KY, Nussenblatt V, Browner I, "Atrial flutter associated with carboplatin administration", Annals of Pharmacotherapy, 2011 Nov .
- Zakaria S, Lu KY, Nussenblatt V, Browner I, "Atrial flutter associated with carboplatin administration", Annals of Pharmacotherapy, 2011 Nov .
How the study uses the data?
The study uses data from the FDA. It is based on carboplatin (the active ingredients of Paraplatin) and Paraplatin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Toprol-Xl cause Irritability? - 4 seconds ago
- Could Androgel cause Muscle Spasms? - 4 seconds ago
- Sulfasalazine and Cardiac Failure for Men aged 60+ - 8 seconds ago
- Infection and Conversion Disorder - 8 seconds ago
- Zopiclone and Vitamin K1 drug interactions for men aged 50-59 - 10 seconds ago
- Could Kineret cause Fatigue Aggravated? - 12 seconds ago
- Could Topamax cause Lipids Abnormal? - 19 seconds ago
- Elavil and Dry Eyes for Women aged 60+ - 19 seconds ago
- Elavil and Dry Eye for Women aged 60+ - 20 seconds ago
- Elavil and Tearing - Decreased for Women aged 60+ - 20 seconds ago